FDA updates labeling for ULTIVA
Labeling changes approved for MYLAN INSTITUTIONAL. Active ingredient: REMIFENTANIL HYDROCHLORIDE. Decision date: 12/22/2025
Labeling changes approved for MYLAN INSTITUTIONAL. Active ingredient: REMIFENTANIL HYDROCHLORIDE. Decision date: 12/22/2025
There are no comments here yet...